Literature DB >> 25618

Characterization of cell wall polymers secreted into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis.

R Hakenbeck, S Waks, A Tomasz.   

Abstract

Autolysin-defective pneumococci secrete large quantities of choline-containing cell wall polymers into the growth medium during treatment with inhibitors of peptidoglycan synthesis. The secreted polymers were separated into three fractions by a combination of gel filtration on agarose and sodium dodecyl sulfate-gel electrophoresis. Fraction I had a high apparent molecular size and contained the Forssman antigen in complex with material exhibiting properties of cell wall teichoic acid. Choline-containing polymers of as yet uncharacterized structure were present in both fractions IIA and IIB, and fraction IIA also contained peptidoglycan components.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25618      PMCID: PMC352231          DOI: 10.1128/AAC.13.2.302

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Activation of the alternative pathway by pneumococcal cell walls.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

2.  Peptidoglycan synthesis in Bacillus licheniformis. The inhibition of cross-linking by benzylpenicillin and cephaloridine in vivo accompanied by the formation of soluble peptidoglycan.

Authors:  Z Tynecka; J B Ward
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

3.  Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin.

Authors:  E JAWETZ; J B GUNNISON; R S SPECK; V R COLEMAN
Journal:  AMA Arch Intern Med       Date:  1951-03

4.  Coordinated incorporation of nascent peptidoglycan and teichoic acid into pneumococcal cell walls and conservation of peptidoglycan during growth.

Authors:  A Tomasz; M McDonnell; M Westphal; E Zanati
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

5.  Secretion of cell wall polymers into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis.

Authors:  S Waks; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

6.  Lipoteichoic acid: a specific inhibitor of autolysin activity in Pneumococcus.

Authors:  J V Höltje; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

7.  In vitro system for the synthesis of teichoic acid linked to peptidoglycan.

Authors:  R Bracha; L Glaser
Journal:  J Bacteriol       Date:  1976-03       Impact factor: 3.490

8.  Suppression of the lytic and bactericidal effects of cell wallinhibitory antibiotics.

Authors:  R Lopez; C Ronda-Lain; A Tapia; S B Waks; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

9.  The glycolipids from the non-capsulated strain of Pneumococcus I-192R, A.T.C.C. 12213.

Authors:  D E Brundish; N Shaw; J Baddiley
Journal:  Biochem J       Date:  1965-10       Impact factor: 3.857

10.  Formation of cell wall polymers by reverting protoplasts of Bacillus licheniformis.

Authors:  T S Elliott; J B Ward; H J Rogers
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

View more
  11 in total

1.  The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in beta-lactam resistance.

Authors:  Thorsten Mascher; Manuel Heintz; Dorothea Zähner; Michelle Merai; Regine Hakenbeck
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

2.  A novel resistance mechanism against beta-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase.

Authors:  T Grebe; J Paik; R Hakenbeck
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

3.  Secretion of cell wall polymers into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis.

Authors:  S Waks; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

4.  Penicillin tolerance in Streptococcus faecium ATCC 9790.

Authors:  I Said; H Fletcher; A Volpe; L Daneo-Moore
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

5.  Streptococcus pneumoniae proteins released into medium upon inhibition of cell wall biosynthesis.

Authors:  R Hakenbeck; C Martin; G Morelli
Journal:  J Bacteriol       Date:  1983-09       Impact factor: 3.490

6.  Antibiotic-tolerant mutants of Streptococcus pneumoniae that are not deficient in autolytic activity.

Authors:  R Williamson; A Tomasz
Journal:  J Bacteriol       Date:  1980-10       Impact factor: 3.490

7.  Therapeutic relevance of penicillin-induced hypersensitivity of Staphylococcus aureus to killing by polymorphonuclear leukocytes.

Authors:  C Lam; A Georgopoulos; G Laber; E Schütze
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Interactions between antibiotics and human neutrophils in the killing of staphylococci.

Authors:  R K Root; R Isturiz; A Molavi; J A Metcalf; H L Malech
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

9.  Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence.

Authors:  M Bonnet; P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease.

Authors:  Claudia Trappetti; Abiodun D Ogunniyi; Marco R Oggioni; James C Paton
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.